IH revenueFY2025CN¥807.02M
- FY YoY
- -12.5%
- 5Y CAGR
- +8.7%
IH revenue was CN¥807.02M for fiscal 2025 (ended Dec 31, 2025), down 12.5% from fiscal 2024. Compound annual growth was +8.7% over 5 years. It rose in 5 of the last 7 fiscal years.
Financials · IH
iHuman Inc. (IH) financials
For fiscal 2025 (ended Dec 31, 2025), iHuman Inc. reported CN¥807.02M of revenue and CN¥95.40M of net income. Figures are in CNY, the currency of its SEC filings.
- Revenue, FY2025
- CN¥807.02M
- Revenue growth, YoY
- -12.5%
- Net income, FY2025
- CN¥95.40M
- Net income growth, YoY
- -3.2%
- Net margin
- 11.8%
- Free cash flow, FY2025
- CN¥46.41M
- EPS, diluted, FY2025
- CN¥0.36
- EPS growth, YoY
- +0.0%
- Cash
- CN¥1.15B
FY2018FY2025
FY2018FY2025
FY2018FY2025
IH revenue and earnings growth
IH net incomeFY2025CN¥95.40M
- FY YoY
- -3.2%
IH net income was CN¥95.40M for fiscal 2025 (ended Dec 31, 2025), down 3.2% from fiscal 2024. It rose in 1 of the last 3 fiscal years.
IH EPSFY2025CN¥0.36
- FY YoY
- +0.0%
IH diluted EPS was CN¥0.36 for fiscal 2025 (ended Dec 31, 2025), up 0.0% from fiscal 2024.
IH free cash flowFY2025CN¥46.41M
- FY YoY
- -9.2%
- 5Y CAGR
- -25.9%
IH free cash flow was CN¥46.41M for fiscal 2025 (ended Dec 31, 2025), down 9.2% from fiscal 2024. Compound annual growth was -25.9% over 5 years. It rose in 2 of the last 6 fiscal years.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥807.02M | CN¥922.20M | CN¥1.02B | CN¥985.52M | CN¥944.72M | CN¥531.91M | CN¥218.66M | CN¥131.87M |
| Cost of revenue | CN¥259.41M | CN¥282.05M | CN¥296.87M | CN¥294.34M | CN¥284.10M | CN¥166.47M | CN¥84.16M | - |
| Gross profit | CN¥547.61M | CN¥640.15M | CN¥721.27M | CN¥691.17M | CN¥660.62M | CN¥365.44M | CN¥134.49M | CN¥66.01M |
| Research and development | CN¥208.44M | CN¥247.76M | CN¥257.55M | CN¥313.48M | CN¥415.33M | CN¥199.51M | CN¥170.16M | CN¥52.10M |
| Selling, general and admin | CN¥91.44M | CN¥99.25M | CN¥104.33M | CN¥109.19M | CN¥97.44M | CN¥114.67M | CN¥189.43M | CN¥13.99M |
| Operating income | CN¥66.76M | CN¥71.91M | CN¥159.89M | CN¥111.58M | -CN¥54.25M | -CN¥44.45M | -CN¥278.81M | -CN¥22.06M |
| Pre-tax income | CN¥101.79M | CN¥110.60M | CN¥202.57M | CN¥132.77M | -CN¥37.20M | -CN¥37.01M | -CN¥274.23M | -CN¥15.99M |
| Income tax | CN¥6.39M | CN¥12.01M | CN¥21.67M | CN¥22.95M | -CN¥145.0K | CN¥466.0K | CN¥1.36M | CN¥1.61M |
| Net income | CN¥95.40M | CN¥98.59M | CN¥180.91M | CN¥109.82M | -CN¥37.05M | -CN¥37.48M | -CN¥275.60M | -CN¥17.60M |
| EPS, basic | CN¥0.37 | CN¥0.38 | CN¥0.69 | CN¥0.41 | -CN¥0.14 | -CN¥0.21 | -CN¥1.52 | -CN¥0.11 |
| EPS, diluted | CN¥0.36 | CN¥0.36 | CN¥0.66 | CN¥0.41 | -CN¥0.14 | -CN¥0.21 | -CN¥1.52 | -CN¥0.11 |
| Diluted shares | 267.6M | 271.2M | 273.8M | 270.2M | 266.6M | 226.3M | 181.4M | 160.0M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | CN¥1.15B | CN¥1.12B | CN¥1.21B | CN¥1.05B | CN¥855.36M | CN¥861.68M | CN¥104.88M | CN¥6.12M |
| Short-term investments | - | CN¥45.46M | - | - | - | - | - | - |
| Receivables | CN¥47.07M | CN¥52.03M | CN¥60.83M | CN¥79.61M | CN¥56.13M | CN¥77.97M | CN¥20.12M | - |
| Inventory | CN¥21.39M | CN¥23.48M | CN¥16.52M | CN¥19.13M | CN¥28.05M | CN¥16.87M | CN¥20.66M | - |
| Current assets | CN¥1.30B | CN¥1.34B | CN¥1.38B | CN¥1.25B | CN¥1.02B | CN¥1.02B | CN¥163.06M | - |
| Total assets | CN¥1.37B | CN¥1.42B | CN¥1.45B | CN¥1.33B | CN¥1.10B | CN¥1.05B | CN¥168.31M | - |
| Current liabilities | CN¥363.98M | CN¥447.54M | CN¥490.76M | CN¥561.05M | CN¥482.93M | CN¥399.22M | CN¥182.76M | - |
| Total liabilities | CN¥373.19M | CN¥458.80M | CN¥492.69M | CN¥563.95M | CN¥492.51M | CN¥404.29M | CN¥182.76M | - |
| Shareholders' equity | CN¥995.17M | CN¥960.85M | CN¥957.80M | CN¥769.45M | CN¥608.37M | CN¥642.65M | -CN¥135.27M | -CN¥63.73M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | CN¥51.32M | CN¥58.55M | CN¥172.12M | CN¥188.47M | CN¥38.21M | CN¥222.99M | CN¥42.63M | -CN¥4.50M |
| Capital expenditures | CN¥4.90M | CN¥7.45M | CN¥6.51M | CN¥6.59M | CN¥32.28M | CN¥15.91M | CN¥2.39M | CN¥529.0K |
| Free cash flow | CN¥46.41M | CN¥51.10M | CN¥165.61M | CN¥181.88M | CN¥5.93M | CN¥207.08M | CN¥40.24M | -CN¥5.03M |
| Investing cash flow | CN¥40.55M | -CN¥52.76M | -CN¥6.51M | -CN¥32.84M | -CN¥31.95M | -CN¥15.91M | -CN¥2.39M | -CN¥529.0K |
| Financing cash flow | -CN¥56.09M | -CN¥102.28M | -CN¥9.45M | -CN¥6.96M | CN¥410.0K | CN¥571.96M | CN¥58.52M | CN¥10.31M |
| Dividends paid | CN¥39.09M | CN¥35.27M | - | - | - | - | - | - |
| Share repurchases | CN¥17.19M | CN¥9.63M | CN¥9.54M | CN¥6.96M | CN¥164.0K | - | - | - |
| Stock-based compensation | CN¥722.0K | CN¥2.82M | CN¥9.44M | CN¥13.04M | CN¥15.18M | CN¥79.89M | CN¥270.54M | - |
| Depreciation and amortization | CN¥7.75M | CN¥13.66M | CN¥11.69M | CN¥10.83M | CN¥6.42M | CN¥2.81M | CN¥597.0K | CN¥365.0K |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -12.5% | -9.4% | 3.3% | 4.3% | 77.6% | 143.3% | 65.8% | - |
| Net income growth, YoY | -3.2% | -45.5% | 64.7% | - | - | - | - | - |
| EPS growth, YoY | 0.0% | -45.5% | 61.0% | - | - | - | - | - |
| Gross margin | 67.9% | 69.4% | 70.8% | 70.1% | 69.9% | 68.7% | 61.5% | 50.1% |
| Operating margin | 8.3% | 7.8% | 15.7% | 11.3% | -5.7% | -8.4% | -127.5% | -16.7% |
| Net margin | 11.8% | 10.7% | 17.8% | 11.1% | -3.9% | -7.0% | -126.0% | -13.3% |
| Free cash flow margin | 5.8% | 5.5% | 16.3% | 18.5% | 0.6% | 38.9% | 18.4% | -3.8% |
| Return on equity | 9.6% | 10.3% | 18.9% | 14.3% | -6.1% | -5.8% | - | - |
| Return on assets | 7.0% | 6.9% | 12.5% | 8.2% | -3.4% | -3.6% | -163.7% | - |
| Current ratio | 3.57 | 2.98 | 2.82 | 2.23 | 2.10 | 2.56 | 0.89 | - |
Source: XBRL data iHuman Inc. files with the SEC, latest filing dated Apr 24, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
IH peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| IH | CN¥807.02M | -12.5% | CN¥95.40M | 11.8% | $64.9M |
| SE | $22.94B | +36.4% | $1.58B | 6.9% | $47.75B |
| IT | $6.44B | -0.2% | $954.41M | 14.8% | $12.05B |
| RTO | $6.91B | +4.4% | $470.00M | 6.8% | $12.04B |
| SCI | $3.31B | +3.4% | $561.30M | 17.0% | $9.94B |
| EDU | $5.66B | +15.5% | $475.17M | 8.4% | $8.31B |
| HRB | $3.97B | +5.2% | -$325.44M | -8.2% | $6.25B |
| TAL | $3.01B | +33.7% | $530.75M | 17.6% | $5.66B |
| GHC | $5.12B | +4.3% | $496.96M | 9.7% | $5.07B |
IH FAQ
9 questionsWhat is IH revenue?
iHuman Inc. (IH) reported CN¥807.02M of revenue for fiscal 2025 (ended Dec 31, 2025). That is down 12.5% from the year before.Is IH profitable?
Yes. iHuman Inc. earned CN¥95.40M in net income for fiscal 2025 (ended Dec 31, 2025), a net margin of 11.8%.How much cash and debt does IH have?
iHuman Inc. reported CN¥1.15B in cash and cash equivalents on its most recent balance sheet in SEC filings.How fast is IH revenue growing?
iHuman Inc.'s revenue changed -12.5% in fiscal 2025, to CN¥807.02M. Its compound annual growth rate was +8.7% over 5 years.What is IH gross margin?
iHuman Inc.'s gross profit was CN¥547.61M on CN¥807.02M of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of 67.9%.What is IH free cash flow?
iHuman Inc. generated CN¥46.41M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of CN¥51.32M less capital expenditures.What is IH earnings per share?
Diluted earnings per share were CN¥0.36 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did IH last report financial results?
The latest statements here come from iHuman Inc.'s 20-F filed on Apr 24, 2026, covering the period ended Dec 31, 2025.Where does this IH financial data come from?
Quantisnow builds these statements from the structured XBRL data iHuman Inc. files with the SEC. It is provided for information only and is not investment advice.